The Freedman Lab, a component of the Musculoskeletal Translation Innovation Initiative (MTII) at BIDMC, has a primary focus on pioneering innovative solutions to address unmet clinical needs within the musculoskeletal (MSK) domain. Our capabilities encompass a range of disciplines including bioimaging, animal models of disease and injury, biomechanics, biomaterials, drug delivery, biology, trauma, sports medicine, pediatric and aging MSK needs, as well as upper and lower extremity ailments.